Helomics Precision Oncology Insights Program
Helomics announced that it has launched its new Precision Oncology Insights platform, which provides a personalized oncology roadmap for oncologists and their patients. Having been acquired by Precision Therapeutics in June, Helomics will offer the platform as a tool to test living tumor tissue from the patient to determine how the tumors respond to drugs. Helomics then integrates the drug response with other genomic and molecular data. The firm's artificial intelligence knowledge base, D-CHIP (Dynamic Clinical Health Insights), then analyzes the data to generate a roadmap that provides additional context to help personalize patient treatment.
Empirical Bioscience EB Pure Agarose Gel Extraction Kit
Empirical Bioscience has introduced the EB Pure Agarose Gel Extraction Kit, which is designed to isolate small DNA fragments (70 bp to 20 kb) from agarose gel in 15 minutes. The system specifically but reversibly binds DNA or RNA under optimized conditions, allowing proteins and other contaminants to be removed. Empirical claims the process will help guarantee consistent recovery rates in more than 85 percent of cases, while simultaneously removing primer-dimers, primers, nucleotides, proteins, salt, agarose, ethidium bromide, and other impurities. The extracted DNA can be used in most applications including ligations, PCR, sequencing, restriction digestion, or various labeling reactions, the firm said.
IncellDx BioINK PD-L1 CTC Core Kit
IncellDx has launched its BioINK PD-L1 CTC Core Kit, a complete, pre-optimized tool to identify, enumerate, and quantify PD-L1 expression in circulating tumor cells. According to the firm, the kit includes the addition of a separate quantitative control cell cocktail — called OncoTect iO Control Cells — that combines PD-L1 positive epithelial cells, PD-L1 negative epithelial cells, and peripheral blood mononuclear cells. The tool allows labs to assess linearity and lower limits of detection for CTC enumeration with known quantities of cells in a lyophilized standard.
The firm's BioINK technology enables highly sensitive and specific quantification of protein or mRNA expression at a single-cell-by-cell resolution optimized for microfluidic chips.
For more new products and services, please visit the New Products page on our website.